LSX Biotech Public CEO Forum-1

The qualifying criteria of this session is participants must be a CEO, Founder, Co-Founder or President of a US-based, publicly-listed therapeutic Biotech company.

A unique, powerful and valuable space for the candid sharing of experience between 25-30 of the sector’s listed-biotech executives. Like-minded executives are joined by 2 appropriate and value-matched industry stakeholders and partners to provide expertise, experience and best practice on strategic areas of focus. Case studies will also be delivered by a number of executives who have enjoyed success or navigated key challenges in their pursuit of company growth.

Strategic topics include, but not restricted to, drug discovery / development, progressing through the clinic, market / regulatory approval, product launch / channel strategies, business resilience, fundraising, deal making / partnerships and strategic exits.

A pre-registration only, Chatham House Rule forum hosted on Zoom where all participants are active discussants. 

Attendance is free, however executives must satisfy the key criteria points outlined during registration.

Co-hosted by:

  Huron 300x-1

Date: Wednesday 23 June 2021

Timings: 1:00PM - 3:00PM EDT / 12:00 - 2:00PM CST / 10:00AM - 12.00PM PDT

Forum Outline:

Pre-event - Benchmarking survey

10mins - Participant intro's and sharing of benchmarking results

20mins - Co-host case study 1 + Q&A

10mins - Peer case study 1

10mins - Guest speaker

20mins - Co-host case study 2 + Q&A

10mins - Peer case study 2

10mins - Peer-to-peer interactive poll

30mins - General discussion

For sponsorship enquiries contact:

Tom Roberts, VP, Business Development

Tom Roberts-1

For speaker enquiries contact:

Becky Johnson, Conference Director 

Becky Johnson